Pharmanutra S.p.A. (BIT:PHN)

Italy flag Italy · Delayed Price · Currency is EUR
79.10
+0.40 (0.51%)
Apr 28, 2026, 5:35 PM CET
53.00%
Market Cap 753.57M
Revenue (ttm) 132.16M
Net Income (ttm) 20.00M
Shares Out 9.58M
EPS (ttm) 2.09
PE Ratio 37.72
Forward PE 30.97
Dividend 1.20 (1.52%)
Ex-Dividend Date May 5, 2025
Volume 15,489
Average Volume 15,389
Open 81.00
Previous Close 78.70
Day's Range 78.70 - 81.10
52-Week Range 38.75 - 83.30
Beta 0.11
RSI 57.00
Earnings Date May 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for mu... [Read more]

Sector Healthcare
Founded 2000
Employees 128
Stock Exchange Borsa Italiana
Ticker Symbol PHN
Full Company Profile

Financial Performance

In 2025, Pharmanutra's revenue was 132.16 million, an increase of 13.78% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.44%.

Financial Statements

News

There is no news available yet.